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Abstract
Background: Unresolved and prolonged inflammation is a pathological basis of many disorders such as cancer and
multiple organ failure in shock. Interleukin-1 receptor (IL-1R) superfamily consists of IL-1R1 and pathogen pattern
recognition receptor toll-like receptor-4 (TLR4) which, upon ligand binding, initiate pro-inflammatory signaling. The
study objective was to investigate the effect of a diphenyldifluoroketone EF24 on the expression of IL-1R1 and TLR4
in lipopolysaccharide (LPS)-stimulated dendritic cells (DCs).
Methods: Immortalized murine bone marrow-derived JAWS II dendritic cells (DC) were challenged with LPS
(100 ng/ml) for 4 h. The LPS-stimulated DCs were treated with 10 μM of EF24 for 1 h. The expression levels of
IL-1R1 and TLR4 were monitored by RT-PCR, immunoblotting, and confocal microscopy. The effect of EF24 on the
viability and cell cycle of DCs was examined by lactate dehydrogenase assay and flow cytometry, respectively.
Results: EF24 treatment suppressed the LPS-induced TLR4 and IL-1R1 expression in DCs. However, the expression
levels of IL-1RA and IL-1R2 were not influenced by either LPS or EF24 treatments. These effects of EF24 were associated
with a decrease in LPS-induced expression of phospho-NF-kB p65, indicative of its role in the transcriptional control of
IL-1R superfamily members. We did not find any significant effect of EF24 on the proliferation or cell cycle of DCs.
Conclusions: The results suggest that EF24 influences IL-1R superfamily signaling pathway in ways that could have
salutary effects in inflammation. The pluripotent anti-inflammatory actions of EF24 warrant further investigation of EF24
in inflammatory conditions of systemic nature.
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Background
The restoration of local and systemic homeostasis pri-
marily falls in the jurisdiction of innate arm of immune
response, especially in the immediate aftermath of insult.
This response manifests itself as inflammation and is
meant for the elimination of the cause of injury and for
protection from the damage [1]. Unresolved and pro-
longed inflammation has been identified as a culprit in
the pathogenesis of many disorders such as shock, in-
flammatory bowel diseases and cancer [2]. Mild
inflammatory reaction is resolved in normal physio-
logical processing, but moderate-to-severe inflammatory
reaction may take a severe toll at both local as well as
systemic levels. Inflammation, with or without accom-
panying sepsis, has also been implicated in multiple
organ failure in the victims of hemorrhagic shock and is-
chemia/reperfusion injury [3–5].
One of the initial steps in inflammatory process involves
the recruitment of immune cells, such as neutrophils,
monocytes and dendritic cells (DCs). These cells are
equipped with cell surface sensors mainly belonging to the
interleukin-1 receptor (IL-1R) superfamily. The IL-1R
members scout the biological milieu for damage–associ-
ated molecular patterns (DAMPs). Upon stimulation, the
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IL-1R members recruit intracellular adaptor proteins
which initiate a molecular cascade culminating into the
secretion of effector pro-inflammatory cytokines such as
TNF-α and IL-6 [6, 7]. The four major groups of IL-1R
superfamily are populated by receptors for IL-1 and IL-18,
TLRs, an orphan receptor suppression of tumorigenicity 2
(ST2), and single immunoglobulin IL-1R-related (SIGIRR)
[8, 9]. Of these, the most important pro-inflammatory
members of IL-1R superfamily are IL-1R1 and toll-like re-
ceptors (TLRs). The TLR group is characterized by extra-
cellular leucine-rich repeats, whereas IL-1R1 contains
extracellular immunoglobulin (Ig) domains. All the mem-
bers of IL-1R superfamily have a conserved cytosolic do-
main called the Toll − IL-1R (TIR) domain, which activates
some of the common signaling pathways. The pro-
inflammatory effects of IL-1R signaling are primarily medi-
ated by a transcription element nuclear factor-kappa B
(NF-kB) [10]. Given the common signaling pathway via
NF-kB, IL-1R members are attractive targets for controlling
exaggerated inflammation [11–13].
The primary objective of this study was to investigate
the effect of EF24, 3,5-bis(2-fluorobenzylidine)-4-piperi-
done, on the expression of IL-1R members in lipopoly-
saccharide (LPS)-stimulated DCs. This investigation is
an extension of our previous work where we reported
the NF-kB inhibitory activity of EF24 in the LPS-
stimulated DC model [14]. EF24 is a synthetic chalcone
derivative which, because of the presence of α,β-unsatur-
ated carbonyl functionality, participates in nucleophilic
addition in biological systems. Such compounds are
often referred to as Michael acceptors because they are
able to undergo 1,4-additions with thiols. Several syn-
thetic as well as naturally occurring Michael acceptors
are known to exhibit anti-inflammatory activity [15, 16].
The inactivation of NF-κB by Michael acceptors is
thought to be mediated by their interaction with cysteine
residues in either IκB kinase (IKK) or in the DNA-
binding domain of NF-κB [17, 18]. EF24 has been show
to directly inhibit the catalytic activity of IkappaB kinase
(IKK) which is responsible for the phosphorylation of
NF-kB inhibitory protein IkappaB [19]. By inhibiting
IKKβ, EF24 reduces the phosphorylation-dependent
proteasomal degradation of IkappaB which ultimately
results in inhibition of activation and nuclear trans-
location of NF-kB for its transcriptional activity. The
results discussed in this report are indicative of the
pluripotent anti-inflammatory effects of EF24 involv-
ing IL-1R1 and TLR4.
Methods
The chemical synthesis and characterization of EF24
were performed by the procedures published elsewhere
[20]. For the in vitro experiments, an aqueous solution
of EF24 was prepared in endotoxin-free water (<0.1 EU/
ml). A highly-purified lipopolysaccharide (LPS, protein
content <0.6 %) of Escherichia coli O111: B4 was ob-
tained from Calbiochem (Darmstadt, Germany). The pri-
mary rabbit antibodies against mouse antigens were
obtained from Cell Signaling Technology (CST, Danvers,
MA), Santa Cruz Biotech (SCBT, Dallas, TX), Abcam
(Cambridge, MA), and Sigma-Aldrich (Sigma, St. Louis,
MO). Horse radish peroxidase (HRP)-conjugated sec-
ondary goat anti-rabbit IgG antibody was from CST.
Cell culture
JAWS II DC cell line is an immortalized and immature
DC cell line derived from the bone marrow of C57BL/6
mice (ATCC, Manassas, VA). The cells were maintained
in alpha-modified minimum essential medium (Sigma,
St Louis, MO) supplemented with 20 % fetal bovine
serum (FBS), 4 mM L-glutamine, 100 U/ml penicillin,
100 μg/ml streptomycin, 50 μg/ml gentamicin (Invitro-
gen, Grand Island, NY) and 5 ng/ml of recombinant
murine granulocyte macrophage-colony stimulating fac-
tor (GM-CSF; Peprotech, Rocky Hill, NJ). The culture
medium was replaced with fresh medium every 48 h.
The LPS-stimulated DCs model used in this study has
been well-characterized in our previous works [14, 21].
Drug treatment
The cultured cells were treated with LPS at 100 ng/ml
concentration for 4 h, after which 10 μM EF24 was
added for 1 h (post-treatment model). The culture
medium for drug exposure was kept the same as that de-
scribed above. In few experiments, the order of LPS and
EF24 addition was reversed, i.e. the cells were first
treated with EF24 for 1 h, followed by 4 h of LPS treat-
ment (pre-treatment model). Furthermore, in long-term
experiments, DCs were stimulated with LPS for 24 h,
followed by treatment with EF24 for additional 4 h. The
experimental groups included the untreated control
DCs, the cells treated with 10 μM EF24 alone, the cells
treated with 100 ng/ml LPS alone, and the cells treated
with both EF24 and LPS.
Real-time PCR
The total RNA was extracted from DCs using RNAeasy
Mini Kit (Qiagen, Valencia, CA). The purified total RNA
was quantified by using absorbance values at 260 nm. Re-
verse transcriptase reaction was performed for 1 h at 42 °C
using 2 μg of total RNA, 1 μg of oligo(dT), 200 U of M-
MLV reverse transcriptase enzyme, 500 μM dNTP mix and
25 U of RNAase inhibitor (Promega, Madison, WI). The
cDNA was stored at -20 °C till further used. The PCR reac-
tion was performed using SybrGreen II and the Go Taq col-
orless master mix (Promega, Madison, WI). Briefly, each
PCR reaction was set up in triplicate wells in a 96-well plate
in a total volume of 25 μl. The reaction mix contained
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cDNA equivalent to 20 ng of total RNA. The quantitative
values of the genes of interest were normalized using β-
actin as the endogenous reference, and fold increase over
control was calculated using the relative quantification
method (2-ΔΔ Ct method). The mouse primers (Table 1)
were designed and synthesized by either Real Time Primers
(RTP, Elkins Park, PA) or Integrated DNA Technologies
(Coralville, IA).
Immunoblotting
The whole cell lysates of treated JAWS II DCs were pre-
pared in a lysis buffer (25 mM Tris-HCl, pH 7.4) con-
taining 0.1 % SDS, 1 % Igepal, 2 mM EDTA, 1 mM
phenyl methyl sulfonyl fluoride (PMSF), 0.2 mM sodium
orthovanadate, 50 mM NaF, 150 mM NaCl and 1 μg/ml
each of leupeptin and pepstatin. After protein estima-
tion, about 25 μg of total protein was fractionated on
Novex 4-20 % Tris–glycine gradient SDS-PAGE gels
(Invitrogen, Carlsbad, CA). The separated proteins were
electro-transferred onto nitrocellulose membranes using
iBlot gel transfer device (Invitrogen, Carlsbad, CA). The
non-specific sites were blocked by incubating the mem-
branes with 5 % skimmed milk in Tris-buffered saline
with 0.4 % Tween-20 (TBST). The blocked membranes
were incubated overnight at 4 °C with appropriate primary
antibodies in TBST. The primary antibodies against TLR4
(Abcam), IL-1R1 (Abcam), IL-1R2 (SCBT), and IL-1RA
(SCBT) were used at dilutions recommended by the man-
ufacturers. After probing, the membranes were washed
and incubated with HRP-conjugated-anti-rabbit-IgG anti-
body diluted at 1:5,000 in TBST. The immunoreactive
bands were detected by SuperSignal West Femto detec-
tion reagent (Thermo Fischer Scientific, Rockford, IL). In
order to ensure equal protein loading in the wells, the
membranes were stripped using a stripping solution con-
taining 10 % SDS, 0.5 M Tris and β-mercaptoethanol
(35 μl/ml) at 60 °C for 45 min, and re-probed with anti-
actin antibody (Sigma; 1:5,000 in TBST). The blots were
imaged and the densitometric readings for the proteins
were normalized with those of actin.
Confocal microscopy
DCs were seeded at a density of 25,000 cells per well in an
8-well chamber slide (Nalge Nunc international, New York,
USA). After the treatment with LPS (100 ng/ml) and EF24
(10 μM), the cells were fixed for 20 min with ice-cold 3.5 %
paraformaldehyde in PBS. Cell permeabilization was carried
out for 20 min on ice with alpha-MEM medium containing
10 % FBS and 0.05 % saponin and 10 mM HEPES [22]. The
cells were washed with PBS supplemented with 1 % FBS
and 0.05 % saponin (wash buffer). The non-specific binding
sites were blocked using PBS containing 10 % normal
mouse serum (Sigma, St Louis MO) for 1 h at room
temperature. A rabbit polyclonal antibody to mouse TLR4
(Abcam) was added to the cells at a dilution of 1:50 and in-
cubated overnight at 4 °C in a humidified chamber. For
NF-kB activation study, we used mouse reactive rabbit
monoclonal anti-phospho-NF-kB p65 antibody (CST) at a
dilution of 1:200. The cells were washed thrice for 5 min
each and incubated with 10 μg/ml Alexa Fluor 488-
labeled donkey anti-rabbit IgG antibody (Molecular
Probes, Carlsbad, CA) for 1 h. In some experiments,
the cells were also labeled with 100 nM rhodamine-
phalloidin (Cytoskeleton Inc, Denver CO) for 30 min at
room temperature, protected from light. Finally, 1 μg/
ml Hoechst 33342 (Molecular Probes, Carlsbad, CA)
dye was added to the cells. The confocal microscopic
images were obtained at the Oklahoma Medical Re-
search Foundation (Oklahoma City, OK) using the
Zeiss LSM-510META laser scanning confocal micro-
scope. The images were acquired with objective lens of
63X as composites or with the x/y stack sizes of
146.2 μm using the band pass filter specifications at
435-485, 560-615 and 505-530.
IL-1β enzyme-linked immunosorbent assay
Overnight cultures of JAWS II DCs were stimulated
with LPS (100 ng/ml) for 4 h followed by 1 h treatment
with EF24 (10 μM) without changing the medium. The
medium was collected and IL-1β secreted in the medium
of cultured JAWS II DCs was measured by an ELISA kit
for mouse IL-1β from Biolegend (San Diego, CA). The
samples were diluted 1:10 and manufacturer’s recom-
mendations were followed.
Cell viability and cell cycle analysis
JAWS II DCs were seeded at a density of 15,000 cells
per well of a 96-well tissue culture plate and treated with
0.1, 1, 5, 10, 50 μM EF24. After 6, 24, and 48 h of the
treatment, both adherent and non-adherent cells were
assessed for membrane integrity using CytoScan™ LDH
Table 1 Primers for RT-PCR
Gene Sequence
TLR1 Forward 5'- TGC AGG AAC TCA ATG TAG CA -3'
Reverse 5'- TTG ACA AAG TCC CTC AGC TC -3'
TLR2 Forward 5'- GAC GAC TGT ACC CTC AAT GG -3'
Reverse 5'- TTA AAT GCT GGG AGA ACG AG -3'
TLR4 Forward 5'- AGA CCT CAG CTT CAA TGG TG -3',
Reverse 5'- GAG ACT GGT CAA GCC AAG AA -3’
TLR5 Forward 5'- GCT CTC CTG CAG ACG TGT AT -3'
Reverse 5'- AGA TTC CCC GGA ACT TTA TG -3'
TLR6 Forward 5'- TGC AGG AAC TCA ATG TAG CA -3'
Reverse 5'- TTG ACA AAG TCC CTC AGC TC -3'
IL-1R1 Forward 5'- CGC AGA AGC TGA AGT CTA CG -3',
Reverse 5'- CAG GTG GCA GAA ATG CTA GA -3'
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(lactate dehydrogenase) assay kit (GBiosciences, Mary-
land Heights, MO) and following the kit manufacturer’s
instructions. The cell proliferation was examined by hex-
osaminidase assay [23]. Briefly, the medium was removed
and hexosaminidase substrate solution in 7.5 mM citrate
buffer (pH 5), p-nitrophenol-N-acetyl-beta-D-glucosami-
nidase (Calbiochem, San Diego, CA) was added at 60 μl
per well. The plate was incubated at 37 °C in 100 % hu-
midity for 30 min, before stopping the reaction by adding
90 μl of 50 mM glycine containing 5 mM of EDTA
(pH 10.4); absorbance was measured at 405 nm.
To determine the effect of EF24 on cell cycle progres-
sion, we treated JAWS II DCs with 1 and 10 μM EF24 for
24 and 48 h. The vehicle-treated cells were used as a nega-
tive control. After the treatment periods, both adherent
and non-adherent cells were collected and centrifuged at
260 x g for 5 min. The cells were washed with Dulbecco’s
phosphate buffered saline (DPBS) (Gibco, Grand Island,
NY), fixed in 70 % ice-cold ethanol for 1 h, and stained
with a buffer containing 5 μg/ml DNase-free RNase A
(Sigma, St Louis, MO), 0.1 % v/v Triton-X 100 and
0.05 mg/ml propidium iodide (Molecular Probes, Carls-
bad, CA). The stained cells were incubated at 4 °C for
30 min in dark, before measuring the fluorescence using
Becton Dickson FACS Calibur flow cytometer carrying
FL2 detector with a band pass filter at 585/45 nm. The
percent number of hypodiploid cells undergoing apoptosis
(sub-G1) and diploid cells (G0-G1, S and G2-M phases)
were determined by analyzing the histogram charts with
ModFit software (Verity software house, Topsham, ME).
Data analysis
Unless otherwise mentioned all the results were analyzed
by one-way analysis of variance (ANOVA) applying the
Bonferroni post-test using Prism software (GraphPad,
San Diego, CA, USA). p < 0.05 was considered statisti-
cally significant. The RT-PCR results are expressed as
fold changes in comparison with control. To determine
the mean fluorescence intensity (MFI) values from con-
focal images, the fluorescence was quantified in at least
three different fields of view for a total of more than 25
cells. Wherever applicable, the data from various exper-
iments were presented as mean ± standard error of
mean (sem).
Results
We used immortalized C57BL/6 mouse-derived JAWS II
dendritic cells that show typical immunophenotype and
morphology when cultured in presence of GM-CSF. The
characteristics of these immortalized cells have been de-
scribed in our previous reports [14, 24].
EF24 suppresses the LPS-induced TLR4 expression
We investigated the expression of TLR4 in JAWS II DCs
by confocal microscopy, immunoblotting and RT-PCR
analyses (Fig. 1). As expected, the exposure of DCs to
LPS resulted in a significant increase in expression of
TLR4 at both mRNA as well as proteins levels. EF24 sig-
nificantly (p < 0.05) reduced the LPS-induced mRNA
levels of TLR4 (Fig. 1a). The immunoblotting for TLR4
showed that both pre- and post-treatment of DCs with
EF24 (1 μM as well as 10 μM) reduced the expression of
TLR4 protein (Fig. 1b). The confocal microscopy sub-
stantiated that EF24 reduced the LPS-induced TLR4 ex-
pression (Fig. 2). LPS stimulation increased the MFI
values for TLR4 expression by approximately 2.3 fold.
Treatment of LPS-stimulated DCs with EF24 showed
TLR4 expression that was not significantly different
from the control DCs. The suppressive effect of EF24 on
the LPS-induced TLR4 expression was also observed
when LPS exposure was prolonged to 24 h before treat-
ment with EF24 for additional 4 h (Fig. 2b).
In order to investigate whether LPS and EF24 affect
other members of TLR family, we also examined the ex-
pression of TLR1, TLR2, TLR5, and TLR6 transcripts in
LPS-stimulated DCs. LPS as well as EF24 treatment had
Fig. 1 EF24 reduces LPS-induced TLR4 expression in JAWS II DCs. The DCs were treated with 100 ng/ml LPS for 4 h, followed by 1 h treatment
with 1 or 10 μM EF24. (a) TLR4 mRNA expression (mean ± sem) in DCs treated with EF24. (b) TLR4 immunoblot of DCs lysates. The cells were
treated with EF24 either after (↓) or before (↑) LPS addition as described in the material and methods. # p value < 0.05 vs. control and * p value < 0.05
vs. LPS treatment
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no impact on the mRNA levels of these TLRs, showing
that the LPS preparation and EF24 solution used in this
study were pure and not contaminated with ligands of
other pro-inflammatory TLRs (data not shown).
EF24 reduces the LPS-induced IL-1R1 expression
IL-1R1 is the primary glycoprotein receptor for pro-
inflammatory IL-1α and IL-1β cytokines [9]. We found that
LPS treatment of JAWS II DCs significantly increased the
expression of IL-1R1. However, after treatment with EF24,
the LPS-induced IL-1R1 expression was reduced to basal
levels. These effects were observed both at mRNA (Fig. 3a)
as well as protein levels (Fig. 3b). EF24 treatment in un-
stimulated DCS had no effect on the basal expression of
IL-1R1. Another receptor for IL-1α and IL-1β is the type 2
IL-1 receptor (IL-1R2). IL-1R2 lacks intracellular signaling
domain, rendering it incapable of initiating the IL-1-
mediated pro-inflammatory signaling. Therefore, expression
of IL-1R2 as a decoy receptor serves as a ‘molecular trap’
for IL-1, with an overall anti-inflammatory impact [25]. Yet
another member of IL-1 superfamily is a naturally occur-
ring competitive IL-1 receptor antagonist (IL-1RA). Binding
of IL-1RA to IL-1R1 leaves IL-1R1 unable to recruit IL-1R
accessory protein for the transduction of IL-1-mediated ac-
tions [26]. We investigated the effect of treatment with LPS
and EF24 on the expression of IL-1R2 and IL-1RA in DCs
(Fig. 3b, lower panel). We found that LPS had no effect on
the expression of these two IL-1R1 antagonists. EF24 treat-
ment also did not significantly alter the expression of IL-
1R2 and IL-1RA. These results suggest that the anti-
inflammatory effects of EF24 in LPS-stimulated DCs are
most likely not dependent on its effect on the expression of
IL-1R2 and IL-1RA as natural antagonists of IL-1R1
signaling.
We also estimated IL-1β secreted in the medium of
LPS-stimulated and EF24-treated DCs (Fig. 3c). LPS sig-
nificantly increased the medium-bound IL-1β (1.4 × the
basal levels) which was reduced by EF24 treatment.
Fig. 2 Confocal micrographs and corresponding MFI values showing that EF24 inhibits the LPS-induced TLR4-expression in DCs. The DCs were
stimulated for either (a) 4 h or (b) 24 h, followed by 1 h or 4 h of EF24 treatment, respectively. The cells were stained with Hoechst dye (nucleus,
blue) and rhodamine-phalloidin (actin, red) and anti-mouse TLR4 antibody (green). The regions with co-localization of red and green fluorescence
appear yellow. The intensity of green fluorescence representing TLR4 (mean ± sem) was quantified in at least three different fields and analyzed
by one way analysis of variance and applying the Bonferroni post-test. # p value < 0.05 vs. control and * p value < 0.05 vs. LPS treatment
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EF24 alone had no impact on basal level of IL-1β
(Fig. 3c).
EF24 decreases activation of NF-kB
NF-kB is a known regulator of TLR4 and IL1-R1 expres-
sion. We monitored the activation of phospho-NF-kB after
labeling the LPS-stimulated DCs with primary antibody
against the phosphorylated form of p65 subunit of NF-kB
(Fig. 4a). The confocal micrographs provided evidence that
LPS induces the activation of NF-kB in DCs. EF24-
treatment decreased the accumulation of phospho-p65 in-
side the LPS-stimulated DCs. The phospho-p65 MFI
values in LPS-stimulated DCs increased to 4,689 ± 54 units
from control levels of 1,290 ± 44 units (Fig. 4b). EF24 treat-
ment significantly reduced the MFI value to 2,028 ± 21
units, though this value was significantly larger than the
control levels. However, as compared to the EF24-control,
the MFI value in LPS + EF24 group was not significantly
different (Fig. 4b). These confocal results on phospho-p65
localization corroborate our earlier observations that EF24
Fig. 3 EF24 suppresses the LPS-induced IL-1R1 expression and IL-1β secretion in JAWS II DCs. (a) Quantitative-polymerase chain reaction for the
measurement of the IL-1R1 mRNA expression (mean ± sem, fold changes as compared to control) in JAWS II DCs that were LPS (100 ng/ml)-stimulated
for 4 h, followed by treatment with 10 μM EF24. # p value < 0.05 vs. control and * p value < 0.05 vs. LPS treatment. (b) Immunoblots of IL-1R1, IL-1R2,
and IL-1RA expression in JAWS II DCs treated with EF24 and LPS. (c) IL-1β secreted in medium of cultured JAWS II DCs. The data is average (± sem) of
samples from three separate experiments, each estimated in triplicate (# p value < 0.05 vs. control and * p value < 0.05 vs. LPS treatment)
Fig. 4 EF24 reduces expression of phospho-NF-kB p65 in LPS-stimulated DCs. JAWS II DCs were stimulated with LPS (100 ng/ml) for 4 h, followed
1 h by treatment with 10 μM of EF24. (a) For confocal microscopy (63X objective), the nucleus was stained with Hoechst dye (blue), whereas NF-kB
was stained (green) with antibody against the phosphorylated form NF-kB p65. A representative set of images from three separate experiments is
shown. (b) The intensity of green fluorescence representing phospho-NF-kB p65 (mean ± sem) was quantified in at least five different fields per view.
One way analysis of variance and Bonferroni post-test was performed on the data (# p value < 0.05 vs. control and * p value < 0.05 vs. LPS treatment).
(c) The expression of phospho-p65 and total p65 in JAWS II DCs, evaluated by immunoblotting
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reduces the DNA-binding and transcriptional activity of
NF-kB in LPS-treated DCs [14]. We confirmed the effect
of LPS and EF24 on phosphorylation of p65 by immuno-
blotting (Fig. 4c).
EF24 does not affect the viability and growth
characteristics of DCs
Because of the widely known anti-proliferative effects of
EF24 on cancer cells [27, 28, 20, 29], we examined the
growth characteristics of EF24-treated DCs. The effect of
EF24 on the viability of DCs was examined by monitoring
the cell membrane integrity (LDH assay, Fig. 5a) and the
proliferative capacity (hexosaminidase assay, Fig. 5b). We
found that the membrane integrity and proliferation cap-
acity of DCs remained unaffected after treatment with
EF24 in the range of 0.1 - 50 μM. To further substantiate
that EF24 does not affect normal cell growth characteristics
of DCs, we performed cell cycle analysis of EF24-treated
DCs. The histogram charts of propidium iodide-stained,
vehicle-treated DCs are shown in Fig. 5c. Upon EF24 treat-
ment up to 48 h, no major changes were observed in cells
populating various stages of cell cycle. These observations
imply that EF24 is not toxic to the DCs and does not
adversely affect their growth pattern in the dose range used
in this study.
Discussion
In our recently published in vivo studies in a rat model of
hemorrhagic shock, EF24 was found to act as a potent
anti-inflammatory molecule for control of pulmonary in-
flammation [30]. The members of IL-1R superfamily con-
stitute the most important pattern recognition receptors
involved in this inflammatory process. The molecular sig-
naling engendered by the interaction of DAMPs and other
putative ligands with IL-1R members is the earliest re-
sponse in the process [31]. Often, this early and protective
response becomes a vicious and self-damaging inflamma-
tory process, and provides the pathophysiological basis of
multiple organ dysfunction syndrome [32]. As such, timely
management of the inflammatory processes and partici-
pating molecules could prevent significant morbidity and
mortality associated with inflammatory conditions such as
trauma and shock. Herein, we report for the first time the
effect of a chalcone derivative EF24 on the expression of
IL-1R superfamily in LPS-stimulated DC model. The LPS-
stimulated DCs or macrophages are the closest in vitro
models for simulating the sterile inflammatory conditions
observed in the in vivo scenarios of trauma and acute
blood loss without infection. Unlike neutrophils and mac-
rophages, DCs are also able to ‘preserve’ useful informa-
tion about the antigen because of their low destructive
capacity [33]. In other words, DCs are specialized to
cleave exogenic protein to a level suitable for appropriate
expression on class II MHC molecules, whereas
neutrophils and macrophages do so less efficiently because
of relatively higher destruction of antigenic protein se-
quence, often preceded by oxidative protein modification.
We found that EF24 treatment suppressed the expression
of pro-inflammatory IL-1R1 and TLR4, without affecting
the expression of the negative regulators of inflammation,
namely IL-1RA and IL-1R2. These effects of EF24 appear
to be at transcriptional levels, perhaps mediated by NF-kB
transcription factor. The observations are in line with our
previous report, where EF24 potently inhibited NF-kB in
an LPS-stimulated DCs model of sterile inflammation
[14]. The effect of EF24 on NF-kB signaling has been re-
ported to be dependent on its interaction and inhibition
of IKKβ [19].
The two most important members of the IL-1R super-
family are TLR4 and IL-1R1. Although both TLR4 and IL-
1R1 are placed upstream of NF-kB in the signaling net-
work, their expression could be transcriptionally regulated
by NF-kB. The NF-kB-mediated transcriptional control of
TLR4 expression in response to LPS stimulation has been
reviewed elsewhere [34, 35]. NF-kB recruits E2F1 as a tran-
scription partner to activate LPS-responsive genes that in-
clude TLR4 mapped to 9q32-33 location in the
chromosome [34]. In addition to the regulation at tran-
scriptional level, NF-kB also influences TLR4 expression by
post-transcriptional mechanisms. For instance, TLR4
mRNA is stabilized by an RNA-binding protein called hu-
man antigen R (HuR) [35–37]. HuR is a direct transcrip-
tional target of NF-kB [38]. Although it is not clear at
present whether the effect of NF-kB inhibition on HuR is
involved, a recent study has described that GL63 (a COX-2
inhibiting curcumin analog which closely resembles EF24)
reduces the cytoplasmic localization and protein abundance
of HuR in lung cancer H460 cells [39].
Given these reports, it could be speculated that the re-
duced TLR4 expression in our model of LPS-stimulated
DCs is because of EF24-mediated inhibition of NF-kB.
Interestingly, EF24 pre-treatment also suppressed LPS-
induced expression of TLR4 (Fig. 1b). This observation is
significant in suggesting that EF24 could serve as
prophylactic as well as therapeutic agent in inflamma-
tory conditions. It could be explained by the ability of
EF24 to inhibit IKK activation by physically interacting
with its cysteinyl groups [16]. Besides phosphorylation
of IkBα, IKK has been also shown to phosphorylate
RelA/p65 in LPS-stimulated macrophages [40]. Thus,
the inability of IKK-EF24 complex to serve as a kinase
inhibits the induction of canonical NF-kB pathway by
LPS stimulation.
NF-kB also controls the expression of IL-1R1, but by
mechanism different from that for TLR4 expression.
The pro-inflammatory signaling of NF-kB pathway re-
sults in upregulation of synthesis and secretion of IL-1
and IL-6 [41, 42]. The murine IL-1α and IL-1β are
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Fig. 5 Effect of EF24 on the membrane integrity, proliferation, and cell cycle of JAWS II DCs. The cells were exposed to EF24 in the concentration
range of 0.1-50 μM for up to 48 h. Membrane integrity was measured by (a) LDH activity in culture medium, whereas cell proliferation was quantified
by (b) hexosaminidase enzyme assay. All the data (mean ± sem) are presented as percent of control (dotted line). (c) Flow cytometric analyses of cell
cycle in JAWS II DCs treated with EF24 (1 and 10 μM). Propidium iodide staining was used to measure the DNA content of DCs after 24 and 48 h of
EF24 exposure
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mapped close to human region 2q12, but murine IL-1R1
is mapped to chromosome 1 in a region of synteny with
human chromosome 2 [43]. We show in Fig. 4 that EF24
treatment of DCs reduces nuclear translocation of p65
subunit of NF-kB. The nuclear translocation of activated
NF-kB is dependent on phosphorylation of p65 subunit
(Rel A). Therefore, nuclear expression of phosopho-p65
subunit of NF-kB is a marker of NF-kB activation. Acti-
vated NF-kB binds to the promoter regions of pro-
inflammatory genes and upregulates the transcription of
pro-inflammatory cytokines [44]. Proinflammatory IL-
1β, which was induced by LPS treatment of DCs (Fig. 3c),
is also regulated by NF-kB-mediated transcriptional con-
trol [45]. NF-kB inhibition results in reduced levels of
these cytokines, which in turn attenuate the signaling
through IL-1R1. It has been previously shown by us that
EF24 treatment of LPS-stimulated DCs reduces the pro-
duction of pro-inflammatory cytokines [14].
Like in the case of steroids, the suppression of IL-1R
members and reduced content of pro-inflammatory me-
diators could raise a valid question about the undesirable
immunosuppressive side-effects of EF24. In fact much of
the anti-inflammatory effects of steroidal drugs are asso-
ciated with functional suppression of the beneficial as-
pects of immune response [46, 47]. More recently,
Patterson et al reported that fluticasone inhalation im-
pairs the pulmonary clearance of Klebsiella pneumoniae
in a mouse model [47].
However, this concern in the case of EF24 is addressed by
our observation that EF24 does not affect the phagocytic
bacterial uptake or localization in the DCs [48]. Phagocyt-
osis is a highly conserved primary innate mechanism
employed by antigen presenting cells to ward off infection
from the body, and the phagocytic capture and presentation
of antigen is a key feature of functional DCs [33].
Whereas preservation of phagocytic function of
antigen presenting cells is desirable, it is also required
to assess the processes contributing in antigen pres-
entation by DCs. Following phagocytosis, the antigen
presentation phenomenon in DCs employs another
important intracellular process called autophagy. Au-
tophagic process enables the delivery of cytoplasmic
material to the lysosome and presentation of antigen
by MHC class II molecules [49, 50]. In our previous
report we showed that EF24 reduced the expression
of LPS-induced MHC class II, CD80 and CD86 mole-
cules, and abrogated the appearance of dendrites in
DCs [14]. These molecules play a critical role in anti-
gen presentation which is preceded by a conserved
process of autophagy whose role in DC-mediated T
cell priming, antigen presentation, and cytokine pro-
duction has been demonstrated [51, 52]. By monitor-
ing the expression of LC3B expression, we found that
EF24 treatment maintained the basal autophagy
process, but reduced LPS-stimulated autophagy (data
not shown). Exaggerated induction of autophagy in
DCs after LPS treatment could be counterproductive
because of the extensive degradation of antigenic in-
formation. Therefore, the suppressive effect of EF24
on LPS-induced autophagy may be beneficial in pre-
serving antigen information.
Conclusions
The results discussed in this report indicate that
EF24 reduces the expression of pro-inflammatory IL-
1R1 and TLR4. Given the purported mechanism of
action of EF24, this effect is speculated to be
dependent on NF-kB inhibition. Since the discovery
of EF24 [27] and its subsequent testing has revolved
around its potent anti-proliferative activity in cancer
cells [28, 20, 29], a potential concern about the util-
ity of EF24 as an anti-inflammatory agent exists be-
cause of its pro-apoptotic effect. However, we found
no effect of EF24 on the viability and cell cycle of
DCs. Here, it must be noted that these experiments
were carried out in immortalized DCs, and toxicity
of EF24 in primary DCs, such as those derived from
bone marrow, must also be evaluated. These in vitro
observations are suggestive of the potential utility of
EF24 in control of hemorrhage-induced inflammation
because drugs modulating transcriptional control of
inflammatory processes are suggested to be more ef-
fective than steroids and selective COX-2 inhibitors
[53]. We have recently reported that EF24 is remark-
ably effective in suppressing pulmonary inflammation
in a rat model of hemorrhagic shock [30].
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